CA
NZ
UK
AU
IND
US
Clarivate PLC (NYSE: CLVT) has announced the sale of its Life Sciences and Healthcare segment for $600 Million. This move is expected to help the company reduce its debt and increase its margins. The sale is a significant step for Clarivate PLC as it …
Compass Pathways plc (NASDAQ: CMPS) reported interim findings from its ongoing pivotal COMP006 investigation of the synthetic psilocybin formulation known as COMP360. The trial enrolled individuals with treatment‑resistant depression who had experienced prolonged depressive episodes.
Corbus Pharmaceuticals Holdings, Inc. Has announced the appointment of Dr. Leonardo Viana Nicacio as its new Chief Medical Officer, effective from August 3, 2026.
The largest story of the day came fromVertex Pharmaceuticals (NASDAQ: VRTX), which agreed to acquireCrinetics Pharmaceuticals (NASDAQ: CRNX)for$85 per share in cash, valuing the company at approximately$10 billion.
Bundibugyo Ebola and the Global Health Context
Understanding the Binary Risk-Reward Profile
The $100 Billion GLP-1 Market's Fundamental Limitation
Why the Gates Foundation Endorsement Matters
X-Linked Retinitis Pigmentosa: The Disease and Its Burden
Why Reverse Splits Happen and What They Signal
Please wait processing your request...